Concepedia

B Fang

BF

Statistics

Publications

12

Citations

1K

H-Index

11

Active since

1994

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Thoracic Surgery Foundation

University of Washington

B Fang is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and adenovirus vectors.

ORCID

Publications per year

1994–2017

12

Publications

12

In vivo hepatic gene therapy: complete albeit transient correction of factor IX deficiency in hemophilia B dogs.

Mark A. Kay, Charles N. Landen, S R Rothenberg et al. · Proceedings of the National Academy of Sciences · 1994 · 257 citations · Full text

, , +15

Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression.

Liang Ji, B Fang, Nancy Yen et al. · PubMed · 1999 · 244 citations

, , +13

Tumor-specific transgene expression from the human telomerase reverse transcriptase promoter enables targeting of the therapeutic effects of the Bax gene to cancers.

Jian Gu, Shunsuke Kagawa, Masahiro Takakura et al. · PubMed · 2000 · 187 citations

, , +13

Gene Therapy for Hemophilia B: Host Immunosuppression Prolongs the Therapeutic Effect of Adenovirus-Mediated Factor IX Expression

B Fang, Randy C. Eisensmith, H. Wang et al. · Human Gene Therapy · 1995 · 129 citations

, , +16

Mechanisms involved in development of resistance to adenovirus-mediated proapoptotic gene therapy in DLD1 human colon cancer cell line

L Zhang, Jian Gu, Tong Lin et al. · Gene Therapy · 2002 · 48 citations

, , +12

1–5 of 12